Source: Xconomy

HCV: Race to Mine Fungi for Drugs Revs up as Verdine's LifeMine Gets $55M

Can the life sciences industry finally begin to efficiently and systematically exploit the potential treasure trove of drugs hidden in fungi? It seems promising, thanks to cheaper DNA sequencing technologies, artificial intelligence, new academic research, and now the largest funding yet for a startup trying to take on the task. This morning, LifeMine Therapeutics, a [...]

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
1-25
Harold R. Werner's photo - Managing Director of HCV

Managing Director

Harold R. Werner

CEO Approval Rating

69/100

Read more